Leidos Holdings (NYSE: LDOS) Lifts Full-Year Guidance on Q1 Defense Strength
LDOS tightens near flat on strong Q1 results and raised 2026 forecast, driven by robust defense and intelligence demand.
Leidos Holdings Inc. (NYSE: LDOS) is an industrial company, listed on the NYSE. Alpha Stocks Insight has published 2 articles on LDOS since May 5, 2026, most recently "Leidos (NYSE: LDOS) Beats Q2 EPS, Raises 2026 Guidance on $4.56B in Revenue" on Thursday, August 6, 2026. Coverage to date spans Earnings Report, tracking LDOS's earnings, analyst activity, and material corporate events. New coverage is added each trading day.
Adjusted EPS of $3.26 beat the $2.97 consensus by 9.9%, but GAAP net income fell 9.4% , here is what drove the gap and why guidance was raised.
LDOS tightens near flat on strong Q1 results and raised 2026 forecast, driven by robust defense and intelligence demand.
Important Legal Disclaimer
This is for informational purposes only and is not financial, investment, or tax advice. Past performance is no guarantee of future results. We are not licensed advisors. For Swiss residents: This does not constitute a public offer under FINSA. For EU residents: Not MiFID II compliant advice. For US residents: Not SEC-registered advice. Always consult a qualified professional. Investing involves risk of loss.
Affiliate disclosure: This site may contain affiliate links to brokerage platforms. If you open an account through one of our links, we may earn a commission at no additional cost to you. Affiliate relationships do not influence our editorial content or stock coverage decisions.
Important Legal Disclaimer: This is for informational purposes only and is not financial, investment, or tax advice. Past performance is no guarantee of future results. We are not licensed advisors. For Swiss residents: This does not constitute a public offer under FINSA. For EU residents: Not MiFID II compliant advice. For US residents: Not SEC-registered advice. Always consult a qualified professional. Investing involves risk of loss.